Recurrent Rectal Cancer Completed Phase 1 Trials for AUY922 (DB11881)

Also known as: Rectal cancer recurrent / Carcinoma rectum recurrent / Rectal carcinoma recurrent / Carcinoma of rectum recurrent

IndicationStatusPhase
DBCOND0028583 (Recurrent Rectal Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01294826Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal CancerTreatment